Výpis publikací

GUDERNOVÁ, Iva, Silvie TRANTÍRKOVÁ, Barbora EL GHANNAMOVÁ, Bohumil FAFÍLEK, Miroslav VAŘECHA, Lukáš BÁLEK, Eva HRUBÁ, Lucie JONÁTOVÁ, Iva JELÍNKOVÁ, Michaela BOSÁKOVÁ, Lukáš TRANTÍREK, Jiří MAYER a Pavel KREJČÍ. One reporter for in-cell activity profiling of majority of protein kinase oncogenes. eLife. Cambridge: eLife Sciences Publications Ltd., 2017, roč. 6, "e21536", s. 1-14. ISSN 2050-084X. Dostupné z: https://dx.doi.org/10.7554/eLife.21536.

TAYLOR, S. Paige, Michaela BOSÁKOVÁ, Miroslav VAŘECHA, Lukáš BÁLEK, Tomáš BÁRTA, Lukáš TRANTÍREK, Iva JELÍNKOVÁ, Ivan DURAN, Iva VESELÁ, Kimberly N. FORLENZA, Jorge H. MARTIN, Aleš HAMPL, Michael BAMSHAD, Deborah NICKERSON, Margie L. JAWORSKI, Jieun SONG, Hyuk WAN KO, Daniel H. COHN, Deborah KRAKOW a Pavel KREJČÍ. An inactivating mutation in intestinal cell kinase, ICK, impairs hedgehog signalling and causes short rib-polydactyly syndrome. Human Molecular Genetics. Oxford: Oxford University Press, 2016, roč. 25, č. 18, s. 3998-4011. ISSN 0964-6906. Dostupné z: https://dx.doi.org/10.1093/hmg/ddw240.

GUDERNOVÁ, Iva, Iva VESELA, Lukáš BÁLEK, marcela BUCHTOVÁ, Hana DOSEDELOVA, Michaela KUNOVÁ, Jakub PIVNIČKA, Iva JELÍNKOVÁ, Lucie ROUBALOVA, Alois KOZUBÍK a Pavel KREJČÍ. Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short stature syndromes. Human Molecular Genetics. Oxford: Oxford University Press, 2016, roč. 25, č. 1, s. 9-23. ISSN 0964-6906. Dostupné z: https://dx.doi.org/10.1093/hmg/ddv441.

BUCHTOVÁ, marcela, Veronika ORALOVÁ, Anie AKLIAN, Jan MAŠEK, Iva VESELA, Zhufeng OUYANG, Tereza OBADALOVÁ, Žaneta KONEČNÁ, Tereza SPOUSTOVÁ, Tereza POSPÍŠILOVÁ, Petr MATULA, Miroslav VAŘECHA, Lukáš BÁLEK, Iva GUDERNOVÁ, Iva JELÍNKOVÁ, Ivan DURAN, Iveta ČERVENKOVÁ, Shunichi MURAKAMI, Alois KOZUBÍK, Petr DVOŘÁK, Vítězslav BRYJA a Pavel KREJČÍ. Fibroblast growth factor and canonical WNT/beta-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage. Biochimica et Biophysica Acta - Molecular Basis of Disease. Amsterdam: ELSEVIER SCIENCE BV, 2015, roč. 1852, č. 5, s. 839-850. ISSN 0925-4439. Dostupné z: https://dx.doi.org/10.1016/j.bbadis.2014.12.020.

SKENDER, Belma, Jiřina HOFMANOVÁ, Josef SLAVÍK, Iva JELÍNKOVÁ, Miroslav MACHALA, Marry Pat MOYER, Alois KOZUBÍK a Alena HYRŠLOVÁ VACULOVÁ. DHA-mediated enhancement of TRAIL-induced apoptosis in colon cancer cells is associated with engagement of mitochondria and specific alterations in sphingolipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. AMSTERDAM: ELSEVIER SCIENCE BV, 2014, roč. 1841, č. 9, s. 1308-1317. ISSN 1388-1981. Dostupné z: https://dx.doi.org/10.1016/j.bbalip.2014.06.005.

JELÍNKOVÁ, Iva, Barbora ŠAFAŘÍKOVÁ, Olga Vondalova BLANAROVA, Belma SKENDER, Jiřina HOFMANOVÁ, Petr SOVA, Mary Pat MOYER, Alois KOZUBÍK, Zdenek KOLAR, Jiri EHRMANN a Alena Hyrslova VACULOVA. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway. Biochemical Pharmacology. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2014, roč. 92, č. 3, s. 415-424. ISSN 0006-2952. Dostupné z: https://dx.doi.org/10.1016/j.bcp.2014.09.013.

VONDÁLOVÁ BLANÁŘOVÁ, Olga, Iva JELÍNKOVÁ, Alena HYRŠLOVÁ VACULOVÁ, P. SOVA, Jiřina HOFMANOVÁ a Alois KOZUBÍK. Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells. Cell Proliferation. 2013, roč. 46, č. 6, s. 665-676. ISSN 0960-7722. Dostupné z: https://dx.doi.org/10.1111/cpr.12061.

LAUKOVÁ, Jarmila, Iva JELÍNKOVÁ, Jiřina HOFMANOVÁ, Nicol STRAKOVÁ, Petr SOVA, Jiří EHRMANN, Zdeněk KOLÁŘ, Alois KOZUBÍK a Alena HYRŠLOVÁ VACULOVÁ. Rosiglitazone acts as an efficient modulator of LA-12-induced cytotoxic and cytostatic response of colon cancer cells. In V4 International Conference of Analytic cytometry VII, 21.-24. September 2013, Mikulov, Czech Republic. 2013.

LAUKOVÁ, Jarmila, Iva JELÍNKOVÁ, Jiřina HOFMANOVÁ, Petr SOVA, Alois KOZUBÍK a Alena HYRŠLOVÁ VACULOVÁ. Rosiglitazone efficiently sensitizes human colon cancer cells to LA-12-induced apoptosis. In The Student Scientific Conference on Biotechnology and Biomedicine, 10.-12. April 2013, Brno, Czech Republic. 2013.

LAUKOVÁ, Jarmila, Iva JELÍNKOVÁ, Jiřina HOFMANOVÁ, Petr SOVA, Alois KOZUBÍK a Alena HYRŠLOVÁ VACULOVÁ. The novel combination of rosiglitazone and platinum (IV) compound LA-12 exerts cooperative cytotoxic effects in colon cancer cells associated with activation of mitochondrial apoptotic pathway. In EMBO Workshop - Mitochondria, Apoptosis and Cancer 2013, 10.-12. October, Stockholm, Sweden 2013. 2013.

LAUKOVÁ, Jarmila, Iva JELÍNKOVÁ, Nicol STRAKOVÁ, Jiřina HOFMANOVÁ, Petr SOVA, Alois KOZUBÍK a Alena HYRŠLOVÁ VACULOVÁ. Rosiglitazone-mediated enhancement of LA-12-induced colon cancer cell apoptosis was associated with stimulation of mitochondrial pathway. In XXIII. biochemical congress, 26. – 29. August 2012, Brno, Czech Republic. 2012.

VONDÁLOVÁ BLANÁŘOVÁ, Olga, Iva JELÍNKOVÁ, Arpad SZOEOR, Belma SKENDER, Karel SOUČEK, Viktor HORVÁTH, Alena VACULOVÁ, Ladislav ANDERA, Petr SOVA, Janos SZOELLOSI, Jiřina HOFMANOVÁ, Gyoergy VEREB a Alois KOZUBÍK. Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway. Carcinogenesis. Oxford: Oxford University Press, 2011, roč. 32, č. 1, s. 42-51. ISSN 0143-3334. Dostupné z: https://dx.doi.org/10.1093/carcin/bgq220.

SKENDER, Belma, Iva JELÍNKOVÁ, Jiřina HOFMANOVÁ, Alois KOZUBÍK a Alena HYRŠLOVÁ VACULOVÁ. Flow cytometric analysis of apoptotic molecular changes at the level of mitochondria. In International Conference Analytical Cytometry VI., 8. - 11. 10. 2011, Praha. 2011.

HYRŠLOVÁ VACULOVÁ, Alena, Iva JELÍNKOVÁ, Barbora BUJOKOVÁ, Belma SKENDER, Olga VONDÁLOVÁ BLANÁŘOVÁ, Silvie TOMÁNKOVÁ, Lenka KOČÍ, Karel SOUČEK, Jiřina HOFMANOVÁ, L ANDĚRA, P SOVA a Alois KOZUBÍK. Novel effective strategies for sensitization of colon and prostate cancer cells to trail-induced apoptosis. In International Conference Analytical Cytometry VI., 8. - 11. 10. 2011, Praha. 2011.

KOZUBÍK, Alois, Olga VONDÁLOVÁ BLANÁŘOVÁ, Alena HYRŠLOVÁ VACULOVÁ, Iva JELÍNKOVÁ, Belma SKENDER, Karel SOUČEK, Viktor HORVÁTH, P SOVA, Jan VONDRÁČEK, Nicol STRAKOVÁ a Jiřina HOFMANOVÁ. Novel platinum cytostatics and potential mechanisms of their action. In XXVI. Xenobiochemické sympózium, 7. – 9. 9. 2011, Trenčianské Teplice. 2011.

SKENDER, Belma, Olga VONDÁLOVÁ BLANÁŘOVÁ, Iva JELÍNKOVÁ, Jiřina HOFMANOVÁ a Alois KOZUBÍK. Flow cytometric analysis of TNF-related apoptosis inducing ligand (TRAIL) internalization. In International Conference ANALYTICAL CYTOMETRY V, Olomouc. 2009.

SKENDER, Belma, Olga VONDÁLOVÁ BLANÁŘOVÁ, Iva JELÍNKOVÁ, Jiřina HOFMANOVÁ, Karel SOUČEK a Alois KOZUBÍK. Flow cytometric analysis of TNF-related apoptosis inducing ligand (TRAIL) internalization. In International Conference ANALYTICAL CYTOMETRY V, Olomouc, 5. – 8. 9. 2009. 2009.